Concepedia

Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion

André Lamy, John W. Eikelboom, Tej Sheth, Stuart J. Connolly, Jackie Bosch, Keith A.A. Fox, Jun Zhu, Eva Lonn, Gilles R. Dagenais, Petr Widimský,

Journal of the American College of Cardiology · 2019 · 95 citations · 18 references

Concepts

MedicineCardiologyPharmacotherapyCardiothoracic SurgeryCardiovascular PharmacotherapyPreventive CardiologyAnticoagulant TherapyAntiplatelet TherapyAntithrombotic TherapyCoronary Artery DiseaseCoronary Artery SurgeryThrombosis PreventionAnticoagulation During Coronary InterventionBleeding Risk ReductionCoronary Artery Disease Pharmacotherapy

References

18

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients

Sam Schulman, Clive Kearon · Journal of Thrombosis and Haemostasis · 2005 · 4.9K citations

Medicine, Hematology, Pharmacology +12

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

John W. Eikelboom, Stuart J. Connolly, Jackie Bosch et al. · New England Journal of Medicine · 2017 · 2.4K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration

Salim Yusuf, David M. Zucker, Eugene R. Passamani et al. · The Lancet · 1994 · 2.1K citations

Medicine, Cardiology, Surgery +6

Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes

New England Journal of Medicine · 2006 · 1.2K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

On-Pump versus Off-Pump Coronary-Artery Bypass Surgery

A. Laurie Shroyer, Frederick L. Grover, Brack Hattler et al. · New England Journal of Medicine · 2009 · 1.1K citations

Medicine, Cardiology, Surgery +10